Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bellingham, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clackamas, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Effingham, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Eureka, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Glenview, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kennewick, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Livonia, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Maplewood, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Middletown, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Minocqua, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Muskegon, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Peru, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Racine, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Reading, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sainte Genevieve, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Shelton, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sheridan, WY
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Summit, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Traverse City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Two Rivers, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Weston, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Willmar, MN
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boise, ID
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Niles, IL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Nephrology / Urology, Neurology Clinical Trial
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Flint, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Bradenton, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Elyria, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Gainesville, GA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Glendale, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Lansing, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Pensacola, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Raleigh, NC
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Riverside, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Staten Island, NY
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Urbana, IL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Waco, TX
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Waukesha, WI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
Status: Enrolling
Updated: 12/31/1969
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Anaplastic Thyroid Cancer Clinical Trial
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Compassionate Use Program For Subcutaneous (SC) Belimumab
Status: Enrolling
Updated: 4/25/2017
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
AVID100 in Advanced Epithelial Carcinomas
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Renal Cell Carcinoma, Metastatic Clinical Trial
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Status: Enrolling, Phase II
Updated: 9/27/2017
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Saline Hypertonic in Preschoolers + CT
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Saline Hypertonic in Preschoolers + CT
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Hemophilia A Clinical Trial
A Gene Transfer Study for Hemophilia A
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Cervical Carcinoma Clinical Trial
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Cervical Carcinoma Clinical Trial
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Louisville, KY
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea
Status: Enrolling
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Multi-Level Degenerative Lumbosacral Spinal Conditions Clinical Trial
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status: Enrolling
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multi-Level Degenerative Lumbosacral Spinal Conditions Clinical Trial
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status: Enrolling
Updated: 12/31/1969
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Multi-Level Degenerative Lumbosacral Spinal Conditions Clinical Trial
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Multi-Level Degenerative Lumbosacral Spinal Conditions Clinical Trial
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status: Enrolling
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Multi-Level Degenerative Lumbosacral Spinal Conditions Clinical Trial
A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Status: Enrolling
Updated: 12/31/1969
mi
from
Vail, CO
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Neurology Clinical Trial
Duke Scleroderma Clinic Patient Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Neurology Clinical Trial
Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Trial
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Invasive Fungal Infection Clinical Trial
Registry of Patients Treated With Systemic Mold-Active Triazoles
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials